ResearchIn-Press PreviewImmunologyOncology
Open Access |
10.1172/jci.insight.201731
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Young, E. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Johnson, C. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Lee, A. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Morris II, D. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Edmondson, G. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Ramirez-Ristori, A.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Tsui, J.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Breese, M. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Camara Serrano, J. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Schott, C. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Abram, C. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Leung, S.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Sayles, L.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Pettiwala, A. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Gutierrez Vera, V. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Lowell, C.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by
Combes, A.
in:
PubMed
|
Google Scholar
|
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by McEachron, T. in: PubMed | Google Scholar
1Division of Pediatric Oncology, UCSF, San Francisco, United States of America
2Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States of America
3UCSF CoLabs, UCSF, San Francisco, United States of America
4Center for Computational Biology and Bioinformatics, Department of Medical, Indiana University School of Medicine, Indianapolis, United States of America
5Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, United States of America
6Department of Pathobiology, University of Guelph, Ontario Veterinary College, Guelph, Canada
7Department of Laboratory Medicine, UCSF, San Francisco, United States of America
8Division of Radiation Oncology, UCSF, San Francisco, United States of America
9Helen Diller Family Comprehensive Cancer, UCSF, San Francisco, United States of America
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Besthesda, United States of America
Find articles by Sweet-Cordero, E. in: PubMed | Google Scholar
Published October 22, 2026 - More info
An immunosuppressive, macrophage-rich tumor microenvironment (TME) is a barrier to immunotherapy across many cancers including osteosarcoma, where immunotherapy has largely failed. cGAS-STING agonism has been explored to inflame such tumors, yet the mechanisms of STING-mediated TME remodeling remain poorly understood, especially in sarcomas. Using multi-modal single cell analysis, we show that systemic STING agonism in osteosarcoma triggers a myeloid-predominant inflammatory response and rapid tumor necrosis, followed by a T cell-mediated response, immunologic memory, and long-term cure in some models. Within two hours of treatment, STING agonism induces pro-inflammatory interferon programs in tumor-associated macrophages and monocytes, with additional contributions from endothelial cells. Efficacy persists in the absence of tumor-intrinsic STING or IFNAR, confirming that the therapeutic axis resides within the host TME rather than the tumor cell compartment. While cGAS-STING is frequently repressed in human osteosarcoma models of aggressive disease, a STING activation gene signature predicts survival in newly diagnosed patients, suggesting that this pathway is engaged during tumor progression. Together, these data identify an opportunity to exploit the myeloid compartment of osteosarcoma with STING pathway therapies, charting a path forward for engaging the TME to secure long term cure in an aggressive malignancy still treated with highly toxic chemotherapy.